Clinical outcome and safety of neuromodulation for severe traumatic brain injury in terms of neurological recovery

Phramongkutklao hospital foundation0 个研究点目标入组 68 人开始时间: 2024年3月25日最近更新: 2024年8月19日

试验速览

暂无简介。

•1. all the adult patients with severe disability (GOS of 2 and 3) after trauma or stroke
•2. Age more than 20 years
•3. Patients have focal neurological deficits presenting with magnetic resonance imaging (MRI) brain or computed tomography (CT) head suggestive of MCA territory AIS presenting within 24 hour of symptom onset, National Institute of Health Stroke Scale (NIHSS) score of >4 and with a modified Rankin Scale (mRS) score of 0 or 1 before the stroke were included in this study.

•Patients with brainstem strokes, transient ischemic attacks, brain tumor, demyelinating diseases, inflammatory diseases, craniotomies, hepatic failure, congestive heart failure, acute myocardial infarction, pregnancy and lactation, systemic malignancy, acute or chronic renal failure, and known allergy to above group of drugs.

发起方

Phramongkutklao hospital foundation